Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment

Oncotarget

Volumn 5, Issue 6, 2014, Pages 1595-1608

  Chen, Po Chun ^a,b   Cheng, Hsu Chen ^c   Wang, John ^d   Wang, Shin Wei ^e   Tai, Huai Ching ^f,g   Lin, Chiao Wen ^b,h   Tang, Chih Hsin ^a,i,j  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e MACKAY MEDICAL COLLEGE   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^h CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

ⁱ CHINA MEDICAL UNIVERSITY   (Taiwan)

^j ASIA UNIVERSITY   (Taiwan)

more..

Author keywords

Angiogenesis; CCN3; M2 macrophage; Prostate cancer; VEGF

Indexed keywords

FOCAL ADHESION KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; NEUTRALIZING ANTIBODY; PROTEIN KINASE B; VASCULOTROPIN; CULTURE MEDIUM; FOCAL ADHESION KINASE 1; NOV PROTEIN, HUMAN; PTK2 PROTEIN, HUMAN; SMALL INTERFERING RNA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CULTURE MEDIUM; CYTOLOGY; DRUG SCREENING; ENZYME IMMUNOASSAY; GENETICS; MALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHARMACOLOGY; PROSTATE TUMOR; SCID MOUSE; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL PROGENITOR CELLS; FOCAL ADHESION KINASE 1; HUMANS; IMMUNOENZYME TECHNIQUES; MACROPHAGES; MALE; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; NF-KAPPA B; PHENOTYPE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904248117     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1570     Document Type: Article

References (43)

1. Robinson DR, Zylstra CR and Williams BO. Wnt signaling and prostate cancer. Curr Drug Targets. 2008; 9(7):571-580.
2. Nelson WG, De Marzo AM and Isaacs WB. Prostate cancer. N Engl J Med. 2003; 349(4):366-381.
3. Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008; 27(45):5904-5912.
4. Mantovani A, Schioppa T, Porta C, Allavena P and Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev. 2006; 25(3):315-322.
5. Lewis CE and Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006; 66(2):605-612.
6. Lin EY and Pollard JW. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 2007; 67(11):5064-5066.
7. Coffelt SB, Hughes R and Lewis CE. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta. 2009; 1796(1):11-18.
8. Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C and Jonjic N. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch. 2002; 440(6):583-588.
9. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J and Perbal B. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol. 1992; 12(1):10-21.
10. Maillard M, Cadot B, Ball RY, Sethia K, Edwards DR, Perbal B and Tatoud R. Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol. 2001; 54(4):275-280.
11. Chen PC, Lin TH, Cheng HC and Tang CH. CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells. Carcinogenesis. 2012; 33(4):937-945.
12. Chen PC, Cheng HC and Tang CH. CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway. Carcinogenesis. 2013.
13. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY and Lau LF. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem. 2003; 278(26):24200-24208.
14. Sica A, Schioppa T, Mantovani A and Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 2006; 42(6):717-727.
15. Faid L, Van Riet I, De Waele M, Facon T, Schots R, Lacor P and Van Camp B. Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma. Eur J Haematol. 1996; 57(5):349-358.
16. Chen Q, Zhang XH and Massague J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell. 2011; 20(4):538-549.
17. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23(11):549-555.
18. Mandal P, Pratt BT, Barnes M, McMullen MR and Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J Biol Chem. 2011; 286(15):13460-13469.
19. Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao YH, Chu CY, Tsai TF, Chiu HC, Dai YS, Inoue H, Yang PC, Kuo ML and Jee SH. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol. 2009; 129(4):1016-1025.
20. Solinas G, Schiarea S, Liguori M, Fabbri M, Pesce S, Zammataro L, Pasqualini F, Nebuloni M, Chiabrando C, Mantovani A and Allavena P. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol. 2010; 185(1):642-652.
21. Murray PJ and Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011; 11(11):723-737.
22. Martinez FO, Helming L and Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009; 27:451-483.
23. Vicioso L, Gonzalez FJ, Alvarez M, Ribelles N, Molina M, Marquez A, Perez L, Matilla A and Alba E. Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer. Am J Clin Pathol. 2006; 125(1):111-118.
24. Bergers G and Benjamin LE. Tumorigenesis and the angiogenic switch. Nature reviews Cancer. 2003; 3(6):401-410.
25. Chen CC and Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009; 41(4):771-783.
26. Tzeng HE, Chen JC, Tsai CH, Kuo CC, Hsu HC, Hwang WL, Fong YC and Tang CH. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway. J Cell Physiol. 2011; 226(12):3181-3189.
27. McCallum L and Irvine AE. CCN3--a key regulator of the hematopoietic compartment. Blood Rev. 2009; 23(2):79-85.
28. Perbal B, Zuntini M, Zambelli D, Serra M, Sciandra M, Cantiani L, Lucarelli E, Picci P and Scotlandi K. Prognostic value of CCN3 in osteosarcoma. Clin Cancer Res. 2008; 14(3):701-709.
29. Perbal B, Lazar N, Zambelli D, Lopez-Guerrero JA, Llombart-Bosch A, Scotlandi K and Picci P. Prognostic relevance of CCN3 in Ewing sarcoma. Hum Pathol. 2009; 40(10):1479-1486.
30. Chen PC, Lin TH, Cheng HC and Tang CH. CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells. Carcinogenesis. 2012.
31. Squadrito ML and De Palma M. Macrophage regulation of tumor angiogenesis: implications for cancer therapy. Mol Aspects Med. 2011; 32(2):123-145.
32. Albini A and Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer. 2007; 7(2):139-147.
33. Bhowmick NA, Neilson EG and Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004; 432(7015):332-337.
34. Bissell MJ, Kenny PA and Radisky DC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol. 2005; 70:343-356.
35. Halin S, Rudolfsson SH, Van Rooijen N and Bergh A. Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. Neoplasia. 2009; 11(2):177-186.
36. Yang W, Wagener J, Wolf N, Schmidt M, Kimmig R, Winterhager E and Gellhaus A. Impact of CCN3 (NOV) glycosylation on migration/invasion properties and cell growth of the choriocarcinoma cell line Jeg3. Hum Reprod. 2011; 26(10):2850-2860.
37. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004; 4(1):71-78.
38. Jun JI and Lau LF. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov. 2011; 10(12):945-963.
39. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L and Bergh A. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol. 2000; 17(3):445-451.
40. Hagemann T, Biswas SK, Lawrence T, Sica A and Lewis CE. Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood. 2009; 113(14):3139-3146.
41. Dornhofer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Hockel M, Le Q, Longaker M, Yang G, Koong A and Giaccia A. Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res. 2006; 66(11):5816-5827.
42. Aikawa T, Gunn J, Spong SM, Klaus SJ and Korc M. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol Cancer Ther. 2006; 5(5):1108-1116.
43. Wang HH, Lin CA, Lee CH, Lin YC, Tseng YM, Hsieh CL, Chen CH, Tsai CH, Hsieh CT, Shen JL, Chan WH, Chang WH and Yeh HI. Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cells. ACS Nano. 2011; 5(6):4337-4344.